| European Case Law Identifier: | ECLI:EP:BA:1999:T022396.19990129 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 29 January 1999 | ||||||||
| Case number: | T 0223/96 | ||||||||
| Application number: | 86300823.1 | ||||||||
| IPC class: | C12N 15/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Vectors and methods for expression of human protein C activity | ||||||||
| Applicant name: | Eli Lilly and Company | ||||||||
| Opponent name: | (01) ZymoGenetics, Inc. (02) Immuno Aktiengesellschaft |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main Request - inventive step (no) First and second auxiliary requests - extension of protection conferred (yes) Third auxiliary request - inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960223eu1.html
Date retrieved: 17 May 2021